ClinicalTrials.gg
RecruitingNCT06949930Updated Apr 29, 2025

OPTIMIZING ROUTINE DELIVERY OF ESSENTIAL CHILD HEALTH AND NUTRITION PACKAGE THROUGH PRIMARY HEALTH CARE CONTACTS

An interventional study of Optimized package of child essential health and nutrition services and Standard package of essential child and nutrition services in Coverage of Vitamin A Supplementation, Coverage of Immunization and Feasibility and Fidelity of Implementation, sponsored by Nutrition International. Recruiting at 2 sites in 2 countries. Open to participants aged 15 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-04-29.

Sponsored by Nutrition International · Not applicable, Interventional, and Health services research

From the registry’s dates

  • Started Feb 2025; still recruiting 1 year 8 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
1,928
Allocation
Non-randomized
Ages
15 Years and older
Sex
All
01

Study summary

The primary objective of the study is to assess whether optimization of an essential package of health and nutrition services for children under five years of age using vitamin A supplementation touch points (i.e., the implementation model) in selected areas in Kenya and Senegal will increase the coverage of vitamin A supplementation and the coverage of other child health and nutrition services. In addition, the study will also assess the feasibility of the implementation model and the drivers of coverage outcomes.

Read the detailed description

Background: Countries have made significant progress over the last 20 years in improving child survival with under five mortality rates. Despite this progress, many countries still experience inequalities in the coverage of several essential child health and nutrition services, including vitamin A supplementation (VAS), growth monitoring and promotion (GMP), immunization, and regular nutrition screening for early detection of malnutrition. Optimizing the delivery of an Essential Child Health and Nutrition Package ("essential package") may address this issue.

Objective: The primary objective of the study is to assess the effect of optimizing the health system for the delivery of the essential package (the "implementation model"), on the coverage of VAS and on the coverage of immunization (as measured by vaccination for measles). In addition, the study will also assess the feasibility of the implementation model and the drivers of coverage outcomes.

Methods: Target population will be children 12-59 months of age and their caregivers in Kisii County in Kenya and Fatick Region in Senegal. The study will use an effectiveness-research implementation hybrid design with two arms: 1) health system will be optimized to deliver VAS to all children 12-59 months of age using all the routine primary health care (PHC) contact points plus current standard of care (Intervention) and 2) current standard of care (Control). The study will be conducted for a period of 18 months. The optimization model will be implemented for 12 months. Baseline and endline surveys that will collect quantitative and qualitative data will be conducted to assess the coverage of essential child health and nutrition services in both arms from study participants per arm in both baseline and endline surveys and to assess implementation feasibility. Implementation fidelity will be assessed through monthly visits by the research team to health facilities.

02

Conditions studied

  • Coverage of Vitamin A Supplementation
  • Coverage of Immunization
  • Feasibility and Fidelity of Implementation

Keywords

  • VAS
  • immunization
  • coverage
  • hybrid effectiveness-implementation research study
  • essential child health and nutrition services
03

In context

Lead sponsor

Nutrition International is the lead sponsor of 4 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
15 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Caregivers of children 12-59 months of age
  • Health service providers

Exclusion criteria

Exclusion Criteria:

  • None
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
1,928 participants (estimated)

Study arms

  • Experimental
    Intervention

    The intervention arm receives the optimized package of child essential health and nutrition services

    Other: Optimized package of child essential health and nutrition services

  • Other
    Control

    The control arm receives the current standard package of health and nutrition services

    Other: Standard package of essential child and nutrition services

Interventions

  • OtherOptimized package of child essential health and nutrition services

    Optimized package of child essential health and nutrition services

  • OtherStandard package of essential child and nutrition services

    Standard package of essential child and nutrition services

06

What researchers measure

Primary outcomes

  1. Children who received their age-appropriate VAS

    The proportion of children 12-59 months of age who received their age-appropriate VAS

    Time frame: From enrollment to the end of intervention at 12 months

  2. Children who are immunized with measles vaccine

    Proportion of children 12-23 months of age who are immunized with one dose of measles (MR1) in Kenya Proportion of children 24-35 months of age who are immunized with the second dose of measles (MR2) in Senegal

    Time frame: From enrollment to the end of intervention at 12 months

  3. Implementation feasibility of new model perceived by health service providers, as assessed by key informant interviews and focus groups

    Feasibility of implementation of the new model as perceived by health service providers will be assessed via key informant interviews and focus groups to enquire on: i. Implementation barriers and facilitators ii. Practicality of implementing the optimization model within context and resource availability iii. Program disruption due to the implementation of the model iv. Need for infrastructure to implement the model v. Sustainability of the optimized model. All qualitative information will be triangulated to assess feasibility of implementation of the new model

    Time frame: From enrollment to the end of intervention at 12 months

  4. Fidelity of implementing the new model

    Fidelity of implementation will be assessed by measuring: i. The proportion of health facilities preparing and using integrated microplans. ii. The proportion of supportive supervision visits carried out in an integrated way. iii. The proportion of service delivery points providing services in an integrated way Fidelity will be achieved if the three parameters score at least 80%.

    Time frame: From enrollment to the end of intervention at 12 months

Secondary outcomes

  1. Co-coverage of VAS and measles vaccine

    Proportion of children 12-23 months of age who have received both their age-appropriate VAS and their age-appropriate vaccines (as measured by measles one) in Kenya Proportion of children 24-35 months of age who have received both their age-appropriate VAS and their age-appropriate vaccines (as measured by measles two) in Senegal

    Time frame: From enrollment to the end of intervention at 12 months

  2. Children screened for malnutrition in the last 6 months

    The proportion of children 12-59 months of age who were screened for malnutrition in the last 6 months

    Time frame: From enrollment to the end of intervention at 12 months

  3. Children who have received growth monitoring service

    The proportion of children 12-59 months who have received growth monitoring service

    Time frame: From enrollment to the end of intervention at 12 months

  4. Children who have received age-appropriate immunizations

    The proportion of children 12-59 months who have received age-appropriate immunizations according to EPI schedule

    Time frame: From enrollment to the end of intervention at 12 months

  5. Caregivers who report receiving more than one service

    The proportion of caregivers of children 12-59 months of age who reported ever receiving more than one of the following services within the Essential Child Health and Nutrition Package during the same visit

    Time frame: From enrollment to the end of intervention at 12 months

  6. Caregivers who indicate are satisfied with the way the services are being delivered

    The proportion of caregivers indicate are satisfied with the way the Essential Child Health and Nutrition Package services are being delivered to their children

    Time frame: From enrollment to the end of intervention at 12 months

07

Study locations

2 of 2 sites recruiting
  • Nutrition International- Kenya
    Nairobi, Kenya
    Recruiting
    • Elijah Mbiti, Ph.D. · Contactembiti@nutritionintl.org · +254709688000
    • Enock Matoke Makori · Contactemakori@nutritionintl.org · +254709688000
    • Elijah Mbiti, Ph.D. · Contact
    • Daniel Lopez de Romana, Ph.D. · Contact
    • Banda Ndiaye, DrPh · Contact
    • Mandana Arabi, M.D., Ph.D. · Contact
    • Alison Greig · Contact
    • Caitlin Gomez, M.S. · Contact
    • Francis Ngure, Ph.D. · Contact
    • Taylor Morrison, M.S. · Contact
    • Geoffrey Kinyua · Contact
    • Richard Onkware · Contact
    • Samuel Onguso · Contact
  • Nutrition International - Senegal
    Dakar, Senegal
    Recruiting
    • Banda Ndiaye · Contactbndiaye@nutritionintl.org · +254780457298
    • Marcel Yanga · Contactmarcelyanga87@gmail.com · +221338693002
    • Banda Ndiaye · Contact
    • Mandana Arabi, M.D., Ph.D. · Contact
    • Daniel Lopez de Romana · Contact
    • Alison Greig · Contact
    • Caitlin Gomez, M.S. · Contact
    • Francis Ngure, Ph.D. · Contact
    • Taylor Morrison, M.S. · Contact
    • Marcel Yanga · Contact
    • Balla Moussa Diedhiou · Contact
    • Mamadou Diop · Contact
    • Papa Birane Mbodji · Contact
    • Assane Ndiaye · Contact
    • Mbacke Sylla · Contact
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Feb 2025 (actual). Primary completion is estimated for Dec 2026, 22 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 14, 2025
First posted
Apr 29, 2025
StartActual
Feb 21, 2025
Primary completionEst.
Dec 2026
CompletionEst.
Mar 2027
Last update
Apr 29, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 29, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06949930
Lead sponsor
Nutrition International
Collaborators
Kenya Ministry of Health, Cheikh Anta Diop University, Senegal, Senegal Ministry of Health, Henike Consultants
Responsible party
Daniel Lopez de Romana (Director Research, Innovation, and Evaluation, Nutrition International) — Principal investigator
First posted
Apr 29, 2025
Start date
Feb 21, 2025
Primary completion
Dec 2026 (estimated)
Completion
Mar 2027 (estimated)
Last update
Apr 29, 2025

Study contacts

Daniel Lopez de Romana, Ph.D.
Contact
dlopezderomana@nutritionintl.org
613-782-6837
Banda Ndiaye, B.S.
Contact
bndiaye@nutritionintl.org
+254780457298
Mandana Arabi, M.D., Ph.D.
principal investigator · Nutrition International
Elijah Mbiti, Ph.D.
principal investigator · Nutrition International

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion